OTCMKTS:POLXF Polydex Pharmaceuticals (POLXF) Stock Price, News & Analysis $1.99 +0.01 (+0.30%) As of 08/7/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Polydex Pharmaceuticals Stock (OTCMKTS:POLXF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get POLXF alerts:Sign Up Key Stats Today's Range$1.99▼$1.9950-Day Range$1.99▼$1.9952-Week Range$0.55▼$2.01Volume2,000 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada. Read More Receive POLXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Polydex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address POLXF Stock News HeadlinesPolydex Pharmaceuticals Limited Shareholders Vote to Approve BioSpectra Inc. Business CombinationJuly 18, 2023 | finance.yahoo.comPolydex Pharmaceuticals Limited: Polydex Pharmaceuticals Issues First Quarter Financial ResultsJune 15, 2023 | finanznachrichten.deTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…July 9 at 2:00 AM | Crypto 101 Media (Ad)Polydex Pharmaceuticals Limited and BioSpectra Inc. Announce Business CombinationApril 27, 2023 | finance.yahoo.comPolydex Pharmaceuticals Ltd.April 17, 2023 | barrons.comPolydex Pharmaceuticals GAAP EPS of -$0.09, revenue of $1.09MSeptember 17, 2022 | seekingalpha.comGlobal Computed Tomography (CT) Scanner Market to Reach $9.38 Billion by 2028 | Demand for AI based CT Scanner is On the RiseSeptember 16, 2022 | nz.finance.yahoo.comPolydex Pharmaceuticals LtdAugust 24, 2022 | reuters.comSee More Headlines POLXF Stock Analysis - Frequently Asked Questions How have POLXF shares performed this year? Polydex Pharmaceuticals' stock was trading at $1.9860 at the beginning of the year. Since then, POLXF stock has increased by 0.0% and is now trading at $1.9860. How do I buy shares of Polydex Pharmaceuticals? Shares of POLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today7/09/2025Fiscal Year End1/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryN/A Current SymbolOTCMKTS:POLXF CIK317158 Webwww.polydex.com Phone(416) 755-2231FaxN/AEmployees20Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$4.41 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (OTCMKTS:POLXF) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polydex Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Polydex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
